Code: JHCD
Adopted: 7/31/25

The ESD recognizes administering a medication to a student and/or permitting a student to administer a
medication to themselves, may be necessary to allow the student to attend school. Therefore, the ESD
allows medication, including injectable medications, to be administered to a student by designated
personnel and the administration of medication by a student to themselves without assistance from
designated personnel, subject to criteria established by the ESD and in accordance with Oregon law.

The ESD shall designate personnel authorized to administer medications to students. Medications,
including injectable medications, may be administered by designated ESD personnel as part of a formal
delegation by a registered nurse. Annual training shall be provided to designated personnel in accordance with law. The training will align with the ODE Medication Administration Training and include discussion of this policy, procedures and materials, including but not limited to, procedures outlined in administrative regulation JHCD-AR - Medications.

When a licensed health care professional is not immediately available, trained personnel designated by the  ESD may administer epinephrine, glucagon, treatment for adrenal insufficiency, or another medication to a student as prescribed and/or as otherwise allowed by Oregon law.

A current first-aid/CPR/AED card is required for designated personnel.

The ESD reserves the right to reject a request for administration of medication at school, either by ESD
personnel or student self-administration, if the medication is not necessary for the student to remain in
school.

The ESD may revoke permission given to a student to self-administer medication if the student does not
responsibly self-administer the medication or abuses the use of the medication, as determined by ESD
personnel.

Medications will be handled, stored, monitored, disposed of and records maintained in accordance with
law and established ESD procedures governing the administration of prescription or nonprescription
medications to students, including procedures for the disposal of sharps and glass.

A process shall be established by which, upon parent or guardian written request, a backup medication is
kept at a reasonably, secure location in the student’s classroom as provided by state law.

A premeasured dose of epinephrine may be administered by trained, designated personnel to any student or other individual on ESD premises who the person believes in good faith is experiencing a severe allergic reaction, regardless of whether the student or individual has a prescription for epinephrine.

A non-injectable short-acting opioid antagonist may be administered to any student or other individual by
ESD personnel (whether or not they have received training on administering medications) on ESD premises who the individual administering the short-acting opioid antagonist believes in good faith is experiencing an opioid overdose.

A school administrator, teacher or other school employee, may administer a short-acting opioid antagonist to a student who experienced or is experiencing an opioid overdose without written permission and instructions of the student’s parents or guardian.

This policy shall not prohibit, in any way, the administration of recognized first aid to a student by ESD
employees in accordance with established state law, Board policy and administrative regulation.

The superintendent shall develop administrative regulations to meet the requirements of law and the
implementation of this policy.

END OF POLICY

Legal Reference(s):
ORS 334.125
ORS 339.866 - 339.871
ORS 433.800 - 433.830
ORS 689.800
OAR 166-400-0010(17)
OAR 166-400-0060(29)
OAR 333-055-0000 - 0035
OAR 581-021-0037
OAR 581-022-2220
OAR 851-047-0000 - 0030

Family Educational Rights and Privacy Act of 1974, 20 U.S.C. § 1232g (2018); Family Educational Rights and Privacy, 34 C.F.R. Part 99 (2019).
OREGON HEALTH AUTHORITY AND OREGON DEPARTMENT OF EDUCATION, Medication Administration: A Manual for School Personnel. House Bill 1552 (2024).